查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1975217

全球器官保存解決方案市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Organ Preservation Solution Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計器官保存解決方案市場將從 2025 年的 3.3569 億美元成長到 2034 年的 6.2027 億美元，2026 年至 2034 年的複合年成長率為 7.06%。

受全球器官移植手術數量不斷成長的推動，全球器官保存解決方案市場正穩步發展。慢性疾病導致的器官衰竭病例增加以及移植成功率的提高，都推動了對高效保存解決方案的需求。這些解決方案在運輸和儲存過程中維持器官活性方面發揮著至關重要的作用。

包括低溫和常溫機械灌注技術在內的保存技術的進步，提高了器官存活率並減少了移植併發症。研究工作正致力於開發能夠延長保存時間並最大限度地減少組織損傷的解決方案。人們對器官捐贈的日益關注以及相關法規結構的完善，也促進了器官市場的擴張。

未來幾年，生物工程和再生醫學領域的創新預計將對市場產生積極影響。研究機構與醫療服務提供者之間合作的加強有望加速產品研發。新興國家移植網路的擴展和物流基礎設施的改善將進一步提升全球對先進保存解決方案的需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球器官保存解決方案市場：依解決方案分類

  • 市場分析、洞察與預測
  • 威斯康辛大學解決方案（UW）
  • Castodiol HTK溶液
  • Perfadex溶液
  • 斯蒂恩溶液
  • Celsiol溶液
  • 低溫症治療液
  • 其他解決方案

第5章 全球器官保存解決方案市場：依保存類型分類

  • 市場分析、洞察與預測
  • 靜態冷藏
  • 低溫機械灌注
  • 室溫機械灌注

第6章 全球器官保存解決方案市場：依器官類型分類

  • 市場分析、洞察與預測
  • 腎
  • 肝
  • 肺
  • 心
  • 其他器官

第7章 全球器官保存解決方案市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 器官移植中心
  • 醫院
  • 其他最終用戶

第8章 全球器官保存解決方案市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Waters Medical Systems LLC
    • Xvivo Perfusion AB
    • Transmedics Inc
    • Preservation Solutions Inc
    • Paragonix Technologies Inc
    • Organox Limited
    • Dr. Franz Koehler Chemie GmbH
    • Accord Healthcare Inc
    • 21st Century Medicine Inc
    • Shanghai Genext Medical Technology
    • Bridge To Life Ltd
    • Transplant Biomedicals
簡介目錄
Product Code: VMR112112117

The Organ Preservation Solution Market size is expected to reach USD 620.27 Million in 2034 from USD 335.69 Million (2025) growing at a CAGR of 7.06% during 2026-2034.

The global organ preservation solution market is growing steadily, supported by the increasing number of organ transplant procedures worldwide. Rising cases of organ failure due to chronic diseases and improved transplant success rates are driving demand for effective preservation solutions. These solutions play a critical role in maintaining organ viability during transportation and storage.

Advancements in preservation technologies, including hypothermic and normothermic machine perfusion techniques, are enhancing organ survival rates and reducing transplant complications. Research efforts are focused on developing solutions that extend preservation time while minimizing tissue damage. Growing awareness about organ donation and supportive regulatory frameworks are also contributing to market expansion.

In the coming years, the market is expected to benefit from innovations in bioengineering and regenerative medicine. Increasing collaborations between research institutions and healthcare providers will likely accelerate product development. Expanding transplant networks and improved logistics infrastructure in emerging economies will further strengthen the global demand for advanced preservation solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Solution

  • University of Wisconsin solution (UW)
  • Custodiol HTK solution
  • Perfadex solution
  • Steen solution
  • Celsior solution
  • Hypothermosol solution
  • Other solutions

By Preservation Type

  • Static cold storage
  • Hypothermic machine perfusion
  • Normothermic machine perfusion

By Organ

  • Kidneys
  • Liver
  • Lungs
  • Heart
  • Other organs

By End-user

  • Organ transplant centers
  • Hospitals
  • Other end-users

COMPANIES PROFILED

  • Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics Inc, Preservation Solutions Inc, Paragonix Technologies Inc, Organox Limited, Dr Franz Koehler Chemie GmbH, Accord Healthcare Inc, 21st Century Medicine Inc, Shanghai Genext Medical Technology, Bridge to Life Ltd, Transplant Biomedicals
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: BY SOLUTION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Solution
  • 4.2. University of Wisconsin solution (UW) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Custodiol HTK solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Perfadex solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Steen solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Celsior solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Hypothermosol solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Other solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: BY PRESERVATION TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Preservation Type
  • 5.2. Static cold storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Hypothermic machine perfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Normothermic machine perfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: BY ORGAN 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Organ
  • 6.2. Kidneys Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Lungs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Heart Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Other organs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Organ transplant centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Other end-users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Solution
    • 8.2.2 By Preservation Type
    • 8.2.3 By Organ
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Solution
    • 8.3.2 By Preservation Type
    • 8.3.3 By Organ
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Solution
    • 8.4.2 By Preservation Type
    • 8.4.3 By Organ
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Solution
    • 8.5.2 By Preservation Type
    • 8.5.3 By Organ
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Solution
    • 8.6.2 By Preservation Type
    • 8.6.3 By Organ
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ORGAN PRESERVATION SOLUTION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Waters Medical Systems LLC
    • 10.2.2 Xvivo Perfusion AB
    • 10.2.3 Transmedics Inc
    • 10.2.4 Preservation Solutions Inc
    • 10.2.5 Paragonix Technologies Inc
    • 10.2.6 Organox Limited
    • 10.2.7 Dr. Franz Koehler Chemie GmbH
    • 10.2.8 Accord Healthcare Inc
    • 10.2.9 21st Century Medicine Inc
    • 10.2.10 Shanghai Genext Medical Technology
    • 10.2.11 Bridge To Life Ltd
    • 10.2.12 Transplant Biomedicals